[Recent and potential drugs for treatment of insomnia].
Terao
Akira
A
Terao_Akira1@takeda.co.jp
Miyamoto
Masaomi
M
D000818:Animals; D053961:Azabicyclo Compounds; D001569:Benzodiazepines; D004155:Diphenhydramine; D015195:Drug Design; D005464:Fluorobenzenes; D058785:GABA-A Receptor Agonists; D006634:Histamine H1 Antagonists; D006801:Humans; D006993:Hypnotics and Sedatives; D007192:Indenes; D064446:Orexin Receptors; D010636:Phenols; D010879:Piperazines; D011725:Pyridines; D044122:Receptor, Melatonin, MT1 / Q000819:agonists; D044123:Receptor, Melatonin, MT2 / Q000819:agonists; D043562:Receptors, G-Protein-Coupled / Q000037:antagonists & inhibitors; D018013:Receptors, Neuropeptide / Q000037:antagonists & inhibitors; D058830:Serotonin 5-HT2 Receptor Antagonists; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy* / Q000209:etiology; D013876:Thiophenes; D000077334:Zolpidem
D053961:Azabicyclo Compounds; D005464:Fluorobenzenes; D058785:GABA-A Receptor Agonists; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D007192:Indenes; D064446:Orexin Receptors; D010636:Phenols; D010879:Piperazines; D011725:Pyridines; D044122:Receptor, Melatonin, MT1; D044123:Receptor, Melatonin, MT2; D043562:Receptors, G-Protein-Coupled; D018013:Receptors, Neuropeptide; D058830:Serotonin 5-HT2 Receptor Antagonists; D013876:Thiophenes; C515050:zopiclone; D001569:Benzodiazepines; C076033:SR 46349B; D000077334:Zolpidem; C469870:indiplon; D004155:Diphenhydramine; C495910:ramelteon